FDA Approved: CYTOMEL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for Cytomel (liothyronine sodium) from Pfizer, leading to changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism

Drugs mentioned

• CYTOMEL (LIOTHYRONINE SODIUM)

Snippet

SUPPL AP for CYTOMEL (LIOTHYRONINE SODIUM)